News

Researchers from the Reeve Irvine Research Center at the University of California, Irvine have published studies demonstrating that human embryonic stem cells (hESC)-derived oligodendroglial progenitor cells (OPCs) could

According to the United Health Foundation, the misuse of over-the-counter medications accounts for a reported 178,000 hospitalizations annually. The campaign aims to tackle this problem by reminding consumers

AC Immune is focused on developing innovative Alzheimer’s disease therapies using vaccination or passive immunization with antibodies. Both the active and passive immunotherapy is directed against the beta

MDX-1100 targets IP-10 (also known as CXCL10), a chemokine associated with the pathogenesis of multiple inflammatory diseases, including ulcerative colitis. Preclinical studies demonstrate that antibodies targeting IP-10 neutralize

The FDA notified Vicuron that it expects to complete the priority review of the dalbavancin new drug application (NDA) on or before September 21, 2005, which is a

Patients who had demonstrated resistance to the standard first-line chemotherapies of cisplatin and/or paclitaxel received phenoxodiol as an adjunct to one of the two traditional therapies. Results suggest

The discovery, outlined in an article in the journal Molecular Cancer Therapeutics, could have important implications for using immunotherapy to treat prostate cancer, according to Ayyappan Rajasekaran, a

The new enzymes, named AttSite Recombinases, catalyze the irreversible integration or excision of DNA sequences at specific locations within the genome, with broad applications in functional genomics, transgenics

The study, named EPICK is designed to demonstrate that PhosLo (calcium acetate) is effective and safe in controlling elevated phosphorus levels (hyperphosphatemia) in stage 4 chronic kidney disease